ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,788Medicare Part D Prescriptions Filled, Including Refills

Rank: 173 out of 680

$574K Total Retail Price of All Prescriptions

Rank: 234 out of 680

593 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 593 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

25% of this provider’s 593 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 9,450 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 450 314 S3 1 4
LISINOPRIL 369 306 2 5
LEVOTHYROXINE SODIUM 361 328 3 2
AMLODIPINE BESYLATE 355 312 4 1
SIMVASTATIN 336 294 5 3
METOPROLOL TARTRATE 304 283 6 12
OMEPRAZOLE 298 258 7 7
METFORMIN HCL 289 207 8 8
CLONIDINE HCL 285 202 9 36
PRAVASTATIN SODIUM 266 241 10 10
FUROSEMIDE 234 194 11 6
HYDRALAZINE HCL 209 168 12 71
GABAPENTIN 175 126 13 15
NIFEDIPINE ER 169 144 14 75
NEXIUM 163 113 15 16
ATORVASTATIN CALCIUM 160 132 16 11
MELOXICAM 154 131 17 24
HYDROCHLOROTHIAZIDE 153 122 18 9
ATENOLOL 152 128 19 19
POTASSIUM CHLORIDE 146 100 20 14
CARVEDILOL 124 92 21 23
ISOSORBIDE DINITRATE 119 100 22 227
ISOSORBIDE MONONITRATE ER 115 98 23 59
GLIMEPIRIDE 112 72 24 29
METOPROLOL SUCCINATE 110 92 25 13
ZOLPIDEM TARTRATE 104 81 26 17
CLOPIDOGREL 99 92 27 26
LOSARTAN POTASSIUM 98 96 28 21
AMLODIPINE BESYLATE-BENAZEPRIL 93 73 29 43
TAMSULOSIN HCL 89 60 30 34
DIOVAN 89 71 30 31
PHENYTOIN SODIUM EXTENDED 82 62 32 115
PANTOPRAZOLE SODIUM 80 74 33 30
TRAMADOL HCL 79 72 34 18
WARFARIN SODIUM 79 71 34 20
OXYBUTYNIN CHLORIDE 77 60 36 129
PLAVIX 76 72 37 39
DONEPEZIL HCL 76 76 37 27
AZITHROMYCIN 74 52 39 42
NIFEDICAL XL 70 56 40 220
NOVOLIN N 69 69 41 225
LYRICA 65 53 42 77
BACLOFEN 65 19 42 140
LANSOPRAZOLE 64 31 44 184
AMITRIPTYLINE HCL 62 46 R 45 47
ACTOS 60 53 46 114
ESCITALOPRAM OXALATE 59 47 47 45
INSULIN SYRINGE 59 53 47 86
NIFEDIAC CC 58 57 49 281
ALENDRONATE SODIUM 58 58 49 32
PROAIR HFA 57 48 51 67
LANTUS 56 20 52 49
BUMETANIDE 55 44 53 102
FOSINOPRIL SODIUM 53 42 54 203
ALLOPURINOL 52 33 55 33
METOCLOPRAMIDE HCL 52 39 55 118
PHENYTOIN 51 21 57 354
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.